Desonide NDC 62332-485

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-485Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0485Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-485-15	62332048515	1 TUBE in 1 CARTON (62332-485-15) / 15 g in 1 TUBEMarketed from Oct 24, 2019
62332-485-60	62332048560	1 TUBE in 1 CARTON (62332-485-60) / 60 g in 1 TUBEMarketed from Oct 24, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desonide
Generic name (nonproprietary): desonide
Active ingredients: Desonide — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212473
Marketing start: Oct 24, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 62332-485_8c111579-9635-4d85-b10d-e42399a751ffSPL ID 8c111579-9635-4d85-b10d-e42399a751ffSPL set ID 9eade7ae-effc-49b5-af7d-8caa183ff252RxCUI 204135UNII J280872D1OUPC 0362332485154, 0362332485604
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332048515 followed by a unit qualifier and the quantity

Package 62332-0485-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 17, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Desonide ointment USP, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212473

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212473
Product	Strength	Form · route	Labeler	Product NDC
Desonide	Desonide .5 mg/g	OintmentTopical	Alembic Pharmaceuticals Limited	46708-485